Review article: Biomedical intelligence
Vol. 148 No. 5152 (2018)
Chronic thromboembolic pulmonary hypertension
- Isabelle Opitz
- Silvia Ulrich
Summary
Chronic thromboembolic pulmonary hypertension (CTEPH) is a potentially fatal disease, which may occur as a rare complication after acute pulmonary embolism, although the exact epidemiology of CTEPH is unknown. The mechanisms involved in nonresolution of thrombotic material and scarring of large and/or small pulmonary arteries are unknown; some risk factors have been identified. To date, CTEPH is still underdiagnosed and undertreated. The cardinal symptom of CTEPH is dyspnoea on exertion, but diagnosis is challenging owing to nonspecific symptoms. Right heart catheterisation is mandatory for the diagnosis of pulmonary hypertension, followed by several imaging methods including besides ventilation/perfusion scan, computed tomography pulmonary angiography and conventional angiography. Operability assessment by a multidisciplinary team is crucial for the management in all CTEPH patients, as pulmonary endarterectomy (PEA) remains the only curative treatment of choice. PEA leads to substantial improvement of haemodynamics, symptoms, and life expectancy enabling many patients to lead unrestricted lives under sole anticoagulation therapy. For inoperable patients or those with disease not amenable to surgery, medical therapy or balloon angioplasty are emerging treatment options. Owing to the complexity of CTEPH, the diagnosis and treatment of CTEPH patients is reserved exclusively to experienced CTEPH centres.
References
- Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J. 2015;46(4):903–75. doi:.https://doi.org/10.1183/13993003.01032-2015
- Gall H, Hoeper MM, Richter MJ, Cacheris W, Hinzmann B, Mayer E. An epidemiological analysis of the burden of chronic thromboembolic pulmonary hypertension in the USA, Europe and Japan. Eur Respir Rev. 2017;26(143):160121. doi:.https://doi.org/10.1183/16000617.0121-2016
- Pepke-Zaba J, Delcroix M, Lang I, Mayer E, Jansa P, Ambroz D, et al. Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry. Circulation. 2011;124(18):1973–81. doi:.https://doi.org/10.1161/CIRCULATIONAHA.110.015008
- Blauwet LA, Edwards WD, Tazelaar HD, McGregor CG. Surgical pathology of pulmonary thromboendarterectomy: a study of 54 cases from 1990 to 2001. Hum Pathol. 2003;34(12):1290–8. doi:.https://doi.org/10.1016/j.humpath.2003.07.003
- Bonderman D, Wilkens H, Wakounig S, Schäfers HJ, Jansa P, Lindner J, et al. Risk factors for chronic thromboembolic pulmonary hypertension. Eur Re777spir J. 2009;33(2):325–31. doi:.https://doi.org/10.1183/09031936.00087608
- Karimi M, Cohan N. Cancer-associated thrombosis. Open Cardiovasc Med J. 2010;4:78–82.
- Simonneau G, Torbicki A, Dorfmüller P, Kim N. The pathophysiology of chronic thromboembolic pulmonary hypertension. Eur Respir Rev. 2017;26(143):160112. doi:.https://doi.org/10.1183/16000617.0112-2016
- Korkmaz A, Ozlu T, Ozsu S, Kazaz Z, Bulbul Y. Long-term outcomes in acute pulmonary thromboembolism: the incidence of chronic thromboembolic pulmonary hypertension and associated risk factors. Clin Appl Thromb Hemost. 2012;18(3):281–8. doi:.https://doi.org/10.1177/1076029611431956
- Otero R, Oribe M, Ballaz A, Jimenez D, Uresandi F, Nauffal D, et al. Echocardiographic assessment of pulmonary arterial pressure in the follow-up of patients with pulmonary embolism. Thromb Res. 2011;127(4):303–8. doi:.https://doi.org/10.1016/j.thromres.2010.12.010
- Poli D, Grifoni E, Antonucci E, Arcangeli C, Prisco D, Abbate R, et al. Incidence of recurrent venous thromboembolism and of chronic thromboembolic pulmonary hypertension in patients after a first episode of pulmonary embolism. J Thromb Thrombolysis. 2010;30(3):294–9. doi:.https://doi.org/10.1007/s11239-010-0452-x
- Surie S, Gibson NS, Gerdes VE, Bouma BJ, van Eck-Smit BL, Buller HR, et al. Active search for chronic thromboembolic pulmonary hypertension does not appear indicated after acute pulmonary embolism. Thromb Res. 2010;125(5):e202–5. doi:.https://doi.org/10.1016/j.thromres.2009.12.016
- Dentali F, Donadini M, Gianni M, Bertolini A, Squizzato A, Venco A, et al. Incidence of chronic pulmonary hypertension in patients with previous pulmonary embolism. Thromb Res. 2009;124(3):256–8. doi:.https://doi.org/10.1016/j.thromres.2009.01.003
- Martí D, Gómez V, Escobar C, Wagner C, Zamarro C, Sánchez D, et al. Incidencia de hipertensión pulmonar tromboembólica crónica sintomática y asintomática [Incidence of symptomatic and asymptomatic chronic thromboembolic pulmonary hypertension]. Arch Bronconeumol. 2010;46(12):628–33. Article in Spanish. doi:.https://doi.org/10.1016/S1579-2129(10)70137-3
- Klok FA, van Kralingen KW, van Dijk AP, Heyning FH, Vliegen HW, Huisman MV. Prospective cardiopulmonary screening program to detect chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism. Haematologica. 2010;95(6):970–5. doi:.https://doi.org/10.3324/haematol.2009.018960
- Noble S, Pasi J. Epidemiology and pathophysiology of cancer-associated thrombosis. Br J Cancer. 2010;102(S1, Suppl 1):S2–9. doi:.https://doi.org/10.1038/sj.bjc.6605599
- Coquoz N, Weilenmann D, Stolz D, Popov V, Azzola A, Fellrath JM, et al. Multicentre observational screening survey for the detection of CTEPH following pulmonary embolism. Eur Respir J. 2018;51(4):1702505. doi:.https://doi.org/10.1183/13993003.02505-2017
- Tiede H, Hoeper MM, Richter M, Cacheris W, Hinzmann B, Mayer E. Global burden of chronic thromboembolic pulmonary hypertension (CTEPH): An epidemiological analysis. Eur Respir J. 2014;44(Suppl 58).
- Lang IM, Dorfmüller P, Noordegraaf AV. The Pathobiology of Chronic Thromboembolic Pulmonary Hypertension. Ann Am Thorac Soc. 2016;13(Suppl 3):S215–21. doi:.https://doi.org/10.1513/AnnalsATS.201509-620AS
- Banks DA, Pretorius GV, Kerr KM, Manecke GR. Pulmonary endarterectomy: part I. Pathophysiology, clinical manifestations, and diagnostic evaluation of chronic thromboembolic pulmonary hypertension. Semin Cardiothorac Vasc Anesth. 2014;18(4):319–30. doi:.https://doi.org/10.1177/1089253214536621
- Ribeiro A, Lindmarker P, Johnsson H, Juhlin-Dannfelt A, Jorfeldt L. Pulmonary embolism: one-year follow-up with echocardiography doppler and five-year survival analysis. Circulation. 1999;99(10):1325–30. doi:.https://doi.org/10.1161/01.CIR.99.10.1325
- Jaff MR, McMurtry MS, Archer SL, Cushman M, Goldenberg N, Goldhaber SZ, et al.; American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; American Heart Association Council on Peripheral Vascular Disease; American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation. 2011;123(16):1788–830. doi:.https://doi.org/10.1161/CIR.0b013e318214914f
- McNeil K, Dunning J. Chronic thromboembolic pulmonary hypertension (CTEPH). Heart. 2007;93(9):1152–8. doi:.https://doi.org/10.1136/hrt.2004.053603
- Kim NH. Group 4 Pulmonary Hypertension: Chronic Thromboembolic Pulmonary Hypertension: Epidemiology, Pathophysiology, and Treatment. Cardiol Clin. 2016;34(3):435–41. doi:.https://doi.org/10.1016/j.ccl.2016.04.011
- Quarck R, Nawrot T, Meyns B, Delcroix M. C-reactive protein: a new predictor of adverse outcome in pulmonary arterial hypertension. J Am Coll Cardiol. 2009;53(14):1211–8. doi:.https://doi.org/10.1016/j.jacc.2008.12.038
- Zabini D, Heinemann A, Foris V, Nagaraj C, Nierlich P, Bálint Z, et al. Comprehensive analysis of inflammatory markers in chronic thromboembolic pulmonary hypertension patients. Eur Respir J. 2014;44(4):951–62. doi:.https://doi.org/10.1183/09031936.00145013
- Reesink HJ, Meijer RC, Lutter R, Boomsma F, Jansen HM, Kloek JJ, et al. Hemodynamic and clinical correlates of endothelin-1 in chronic thromboembolic pulmonary hypertension. Circ J. 2006;70(8):1058–63. doi:.https://doi.org/10.1253/circj.70.1058
- Bonderman D, Jakowitsch J, Redwan B, Bergmeister H, Renner MK, Panzenböck H, et al. Role for staphylococci in misguided thrombus resolution of chronic thromboembolic pulmonary hypertension. Arterioscler Thromb Vasc Biol. 2008;28(4):678–84. doi:.https://doi.org/10.1161/ATVBAHA.107.156000
- Wolf M, Boyer-Neumann C, Parent F, Eschwege V, Jaillet H, Meyer D, et al. Thrombotic risk factors in pulmonary hypertension. Eur Respir J. 2000;15(2):395–9. doi:.https://doi.org/10.1034/j.1399-3003.2000.15b28.x
- Bonderman D, Turecek PL, Jakowitsch J, Weltermann A, Adlbrecht C, Schneider B, et al. High prevalence of elevated clotting factor VIII in chronic thromboembolic pulmonary hypertension. Thromb Haemost. 2003;90(3):372–6. doi:.https://doi.org/10.1160/TH03-02-0067
- Gu S, Su P, Yan J, Zhang X, An X, Gao J, et al. Comparison of gene expression profiles and related pathways in chronic thromboembolic pulmonary hypertension. Int J Mol Med. 2014;33(2):277–300. doi:.https://doi.org/10.3892/ijmm.2013.1582
- Morris TA, Marsh JJ, Chiles PG, Magaña MM, Liang NC, Soler X, et al. High prevalence of dysfibrinogenemia among patients with chronic thromboembolic pulmonary hypertension. Blood. 2009;114(9):1929–36. doi:.https://doi.org/10.1182/blood-2009-03-208264
- Le Gal G, Delahousse B, Lacut K, Malaviolle V, Regina S, Blouch MT, et al.; Groupe d’Etudes sur la Thrombose des Hôpitaux Universitaires du Grand Ouest. Fibrinogen Aα-Thr312Ala and factor XIII-A Val34Leu polymorphisms in idiopathic venous thromboembolism. Thromb Res. 2007;121(3):333–8. doi:.https://doi.org/10.1016/j.thromres.2007.05.003
- Suntharalingam J, Goldsmith K, van Marion V, Long L, Treacy CM, Dudbridge F, et al. Fibrinogen Aα Thr312Ala polymorphism is associated with chronic thromboembolic pulmonary hypertension. Eur Respir J. 2008;31(4):736–41. doi:.https://doi.org/10.1183/09031936.00055107
- Marsh JJ, Chiles PG, Liang NC, Morris TA. Chronic thromboembolic pulmonary hypertension-associated dysfibrinogenemias exhibit disorganized fibrin structure. Thromb Res. 2013;132(6):729–34. doi:.https://doi.org/10.1016/j.thromres.2013.09.024
- Alias S, Redwan B, Panzenböck A, Winter MP, Schubert U, Voswinckel R, et al. Defective angiogenesis delays thrombus resolution: a potential pathogenetic mechanism underlying chronic thromboembolic pulmonary hypertension. Arterioscler Thromb Vasc Biol. 2014;34(4):810–9. doi:.https://doi.org/10.1161/ATVBAHA.113.302991
- Frey MK, Alias S, Winter MP, Redwan B, Stübiger G, Panzenboeck A, et al. Splenectomy is modifying the vascular remodeling of thrombosis. J Am Heart Assoc. 2014;3(1):e000772. doi:.https://doi.org/10.1161/JAHA.113.000772
- Mayer E. Surgical and post-operative treatment of chronic thromboembolic pulmonary hypertension. Eur Respir Rev. 2010;19(115):64–7. doi:.https://doi.org/10.1183/09059180.00007409
- Humbert M. Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiology. Eur Respir Rev. 2010;19(115):59–63. doi:.https://doi.org/10.1183/09059180.00007309
- Moser KM, Bloor CM. Pulmonary vascular lesions occurring in patients with chronic major vessel thromboembolic pulmonary hypertension. Chest. 1993;103(3):685–92. doi:.https://doi.org/10.1378/chest.103.3.685
- Bauer M, Wilkens H, Langer F, Schneider SO, Lausberg H, Schäfers HJ. Selective upregulation of endothelin B receptor gene expression in severe pulmonary hypertension. Circulation. 2002;105(9):1034–6. doi:.https://doi.org/10.1161/hc0902.105719
- Mayer E, Jenkins D, Lindner J, D’Armini A, Kloek J, Meyns B, et al. Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry. J Thorac Cardiovasc Surg. 2011;141(3):702–10. doi:.https://doi.org/10.1016/j.jtcvs.2010.11.024
- Held M, Grün M, Holl R, Walter F, Schäfers HJ, Graeter T, et al. Chronisch thromboembolische pulmonale Hypertonie: Latenz bis zur Diagnosesicherung und klinischer Zustand bei Diagnosestellung [Chronic thromboembolic pulmonary hypertension: Time delay from onset of symtoms to diagnosis and clinical condition at diagnosis]. Dtsch Med Wochenschr. 2014;139(33):1647–52. Article in German.
- Gopalan D, Delcroix M, Held M. Diagnosis of chronic thromboembolic pulmonary hypertension. Eur Respir Rev. 2017;26(143):160108. doi:.https://doi.org/10.1183/16000617.0108-2016
- Fedullo P, Kerr KM, Kim NH, Auger WR. Chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med. 2011;183(12):1605–13. doi:.https://doi.org/10.1164/rccm.201011-1854CI
- Armstrong I, Rochnia N, Harries C, Bundock S, Yorke J. The trajectory to diagnosis with pulmonary arterial hypertension: a qualitative study. BMJ Open. 2012;2(2):e000806. doi:.https://doi.org/10.1136/bmjopen-2011-000806
- Armstrong I, Harries C, Yorke J. The imPAHct survey: living with pulmonary arterial hypertension. Am J Respir Crit Care Med. 2011;183:A6130.
- Al-Naamani K, Hijal T, Nguyen V, Andrew S, Nguyen T, Huynh T. Predictive values of the electrocardiogram in diagnosing pulmonary hypertension. Int J Cardiol. 2008;127(2):214–8. doi:.https://doi.org/10.1016/j.ijcard.2007.06.005
- Bonderman D, Wexberg P, Martischnig AM, Heinzl H, Lang MB, Sadushi R, et al. A noninvasive algorithm to exclude pre-capillary pulmonary hypertension. Eur Respir J. 2011;37(5):1096–103. doi:.https://doi.org/10.1183/09031936.00089610
- Sun XG, Hansen JE, Oudiz RJ, Wasserman K. Pulmonary function in primary pulmonary hypertension. J Am Coll Cardiol. 2003;41(6):1028–35. doi:.https://doi.org/10.1016/S0735-1097(02)02964-9
- Trip P, Nossent EJ, de Man FS, van den Berk IA, Boonstra A, Groepenhoff H, et al. Severely reduced diffusion capacity in idiopathic pulmonary arterial hypertension: patient characteristics and treatment responses. Eur Respir J. 2013;42(6):1575–85. doi:.https://doi.org/10.1183/09031936.00184412
- Coghlan JG, Denton CP, Grünig E, Bonderman D, Distler O, Khanna D, et al.; DETECT study group. Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study. Ann Rheum Dis. 2014;73(7):1340–9. doi:.https://doi.org/10.1136/annrheumdis-2013-203301
- Hoeper MM, Pletz MW, Golpon H, Welte T. Prognostic value of blood gas analyses in patients with idiopathic pulmonary arterial hypertension. Eur Respir J. 2007;29(5):944–50. doi:.https://doi.org/10.1183/09031936.00134506
- Scheidl SJ, Englisch C, Kovacs G, Reichenberger F, Schulz R, Breithecker A, et al. Diagnosis of CTEPH versus IPAH using capillary to end-tidal carbon dioxide gradients. Eur Respir J. 2012;39(1):119–24. doi:.https://doi.org/10.1183/09031936.00109710
- Held M, Meintz S, Baron S, Roth C, Wilkens H, Schäfers HJ, et al. Surgical cure of central sleep apnea? Am J Respir Crit Care Med. 2013;188(3):395–6. doi:.https://doi.org/10.1164/rccm.201210-1944IM
- Held M, Grün M, Holl R, Hübner G, Kaiser R, Karl S, et al. Cardiopulmonary exercise testing to detect chronic thromboembolic pulmonary hypertension in patients with normal echocardiography. Respiration. 2014;87(5):379–87. doi:.https://doi.org/10.1159/000358565
- Held M, Linke M, Jany B. Echokardiographie und Rechtsherzkatheterisierung bei pulmonaler Hypertonie [Echocardiography and right heart catheterization in pulmonal hypertension]. Dtsch Med Wochenschr. 2014;139(30):1511–7. Article in German.
- Konstantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galiè N, et al., Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2014;35(43):3033–73. doi:.https://doi.org/10.1093/eurheartj/ehu283
- Ruggiero A, Screaton NJ. Imaging of acute and chronic thromboembolic disease: state of the art. Clin Radiol. 2017;72(5):375–88. doi:.https://doi.org/10.1016/j.crad.2017.02.011
- Ley S, Ley-Zaporozhan J, Pitton MB, Schneider J, Wirth GM, Mayer E, et al. Diagnostic performance of state-of-the-art imaging techniques for morphological assessment of vascular abnormalities in patients with chronic thromboembolic pulmonary hypertension (CTEPH). Eur Radiol. 2012;22(3):607–16. doi:.https://doi.org/10.1007/s00330-011-2290-4
- Reichelt A, Hoeper MM, Galanski M, Keberle M. Chronic thromboembolic pulmonary hypertension: evaluation with 64-detector row CT versus digital substraction angiography. Eur J Radiol. 2009;71(1):49–54. doi:.https://doi.org/10.1016/j.ejrad.2008.03.016
- Sugiura T, Tanabe N, Matsuura Y, Shigeta A, Kawata N, Jujo T, et al. Role of 320-slice CT imaging in the diagnostic workup of patients with chronic thromboembolic pulmonary hypertension. Chest. 2013;143(4):1070–7. doi:.https://doi.org/10.1378/chest.12-0407
- Thieme SF, Becker CR, Hacker M, Nikolaou K, Reiser MF, Johnson TR. Dual energy CT for the assessment of lung perfusion--correlation to scintigraphy. Eur J Radiol. 2008;68(3):369–74. doi:.https://doi.org/10.1016/j.ejrad.2008.07.031
- Thieme SF, Graute V, Nikolaou K, Maxien D, Reiser MF, Hacker M, et al. Dual Energy CT lung perfusion imaging--correlation with SPECT/CT. Eur J Radiol. 2012;81(2):360–5. doi:.https://doi.org/10.1016/j.ejrad.2010.11.037
- Dournes G, Verdier D, Montaudon M, Bullier E, Rivière A, Dromer C, et al. Dual-energy CT perfusion and angiography in chronic thromboembolic pulmonary hypertension: diagnostic accuracy and concordance with radionuclide scintigraphy. Eur Radiol. 2014;24(1):42–51. doi:.https://doi.org/10.1007/s00330-013-2975-y
- Renard B, Remy-Jardin M, Santangelo T, Faivre JB, Tacelli N, Remy J, et al. Dual-energy CT angiography of chronic thromboembolic disease: can it help recognize links between the severity of pulmonary arterial obstruction and perfusion defects? Eur J Radiol. 2011;79(3):467–72. doi:.https://doi.org/10.1016/j.ejrad.2010.04.018
- Ito K, Kubota K, Morooka M, Shida Y, Hasuo K, Endo H, et al. Diagnostic usefulness of 18F-FDG PET/CT in the differentiation of pulmonary artery sarcoma and pulmonary embolism. Ann Nucl Med. 2009;23(7):671–6. doi:.https://doi.org/10.1007/s12149-009-0292-y
- Hudson ER, Smith TP, McDermott VG, Newman GE, Suhocki PV, Payne CS, et al. Pulmonary angiography performed with iopamidol: complications in 1,434 patients. Radiology. 1996;198(1):61–5. doi:.https://doi.org/10.1148/radiology.198.1.8539407
- Stein PD, Athanasoulis C, Alavi A, Greenspan RH, Hales CA, Saltzman HA, et al. Complications and validity of pulmonary angiography in acute pulmonary embolism. Circulation. 1992;85(2):462–8. doi:.https://doi.org/10.1161/01.CIR.85.2.462
- Kovacs G, Herve P, Barbera JA, Chaouat A, Chemla D, Condliffe R, et al. An official European Respiratory Society statement: pulmonary haemodynamics during exercise. Eur Respir J. 2017;50(5):1700578. doi:.https://doi.org/10.1183/13993003.00578-2017
- Jenkins D, Mayer E, Screaton N, Madani M. State-of-the-art chronic thromboembolic pulmonary hypertension diagnosis and management. Eur Respir Rev. 2012;21(123):32–9. doi:.https://doi.org/10.1183/09059180.00009211
- Berman M, Gopalan D, Sharples L, Screaton N, Maccan C, Sheares K, et al. Right ventricular reverse remodeling after pulmonary endarterectomy: magnetic resonance imaging and clinical and right heart catheterization assessment. Pulm Circ. 2014;4(1):36–44. doi:.https://doi.org/10.1086/674884
- Lewczuk J, Piszko P, Jagas J, Porada A, Sobkowicz B, Wrabec K, et al. Prognostic factors in medically treated patients with chronic pulmonary embolism. Chest. 2001;119(3):818–23. doi:.https://doi.org/10.1378/chest.119.3.818
- Madani MM. Surgical Treatment of Chronic Thromboembolic Pulmonary Hypertension: Pulmonary Thromboendarterectomy. Methodist DeBakey Cardiovasc J. 2016;12(4):213–8. doi:.https://doi.org/10.14797/mdcj-12-4-213
- Kim NH, Delcroix M, Jenkins DP, Channick R, Dartevelle P, Jansa P, et al. Chronic thromboembolic pulmonary hypertension. J Am Coll Cardiol. 2013;62(25, Suppl):D92–9. doi:.https://doi.org/10.1016/j.jacc.2013.10.024
- Jenkins D, Madani M, Fadel E, D’Armini AM, Mayer E. Pulmonary endarterectomy in the management of chronic thromboembolic pulmonary hypertension. Eur Respir Rev. 2017;26(143):160111. doi:.https://doi.org/10.1183/16000617.0111-2016
- Jenkins D. Pulmonary endarterectomy: the potentially curative treatment for patients with chronic thromboembolic pulmonary hypertension. Eur Respir Rev. 2015;24(136):263–71. doi:.https://doi.org/10.1183/16000617.00000815
- Madani MM, Auger WR, Pretorius V, Sakakibara N, Kerr KM, Kim NH, et al. Pulmonary endarterectomy: recent changes in a single institution’s experience of more than 2,700 patients. Ann Thorac Surg. 2012;94(1):97–103, discussion 103. doi:.https://doi.org/10.1016/j.athoracsur.2012.04.004
- Ng C, Jenkins DP. Surgical management of chronic thromboembolic pulmonary hypertension. Br J Hosp Med (Lond). 2013;74(1):31–5. doi:.https://doi.org/10.12968/hmed.2013.74.1.31
- Vuylsteke A, Sharples L, Charman G, Kneeshaw J, Tsui S, Dunning J, et al. Circulatory arrest versus cerebral perfusion during pulmonary endarterectomy surgery (PEACOG): a randomised controlled trial. Lancet. 2011;378(9800):1379–87. doi:.https://doi.org/10.1016/S0140-6736(11)61144-6
- Delcroix M, Lang I, Pepke-Zaba J, Jansa P, D’Armini AM, Snijder R, et al. Long-Term Outcome of Patients With Chronic Thromboembolic Pulmonary Hypertension: Results From an International Prospective Registry. Circulation. 2016;133(9):859–71. doi:.https://doi.org/10.1161/CIRCULATIONAHA.115.016522
- Opitz I, de Perrot M. Technique of Pulmonary Thromboendarterectomy. Oper Tech Thorac Cardiovasc Surg. 2012;17(3):168–80. doi:.https://doi.org/10.1053/j.optechstcvs.2012.07.004
- Jamieson SW, Kapelanski DP. Pulmonary endarterectomy. Curr Probl Surg. 2000;37(3):165–252. doi:.https://doi.org/10.1016/S0011-3840(00)80005-2
- Madani M, Jamieson SW. Pulmonary Endarterectomy for Chronic Thromboembolic Disease. Oper Tech Thorac Cardiovasc Surg. 2006;11(4):264–74. doi:.https://doi.org/10.1053/j.optechstcvs.2006.10.002
- Lindner J, Ambrož D, Novotný R, Nižňanský M, Šimková I, Boháčeková M, et al. Pulmonary endarterectomy combined with cardiac surgery: A 7-year retrospective analysis. Cor Vasa. 2015;57(2):e115–20. doi:.https://doi.org/10.1016/j.crvasa.2015.02.009
- Thistlethwaite PA, Auger WR, Madani MM, Pradhan S, Kapelanski DP, Jamieson SW. Pulmonary thromboendarterectomy combined with other cardiac operations: indications, surgical approach, and outcome. Ann Thorac Surg. 2001;72(1):13–7, discussion 17–9. doi:.https://doi.org/10.1016/S0003-4975(01)02686-8
- Raisinghani A, Ben-Yehuda O. Echocardiography in chronic thromboembolic pulmonary hypertension. Semin Thorac Cardiovasc Surg. 2006;18(3):230–5. doi:.https://doi.org/10.1053/j.semtcvs.2006.09.006
- Saouti N, de Man F, Westerhof N, Boonstra A, Twisk J, Postmus PE, et al. Predictors of mortality in inoperable chronic thromboembolic pulmonary hypertension. Respir Med. 2009;103(7):1013–9. doi:.https://doi.org/10.1016/j.rmed.2009.01.017
- Rahnavardi M, Yan TD, Cao C, Vallely MP, Bannon PG, Wilson MK. Pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension : a systematic review. Ann Thorac Cardiovasc Surg. 2011;17(5):435–45. doi:.https://doi.org/10.5761/atcs.oa.10.01653
- Condliffe R, Kiely DG, Gibbs JS, Corris PA, Peacock AJ, Jenkins DP, et al. Improved outcomes in medically and surgically treated chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med. 2008;177(10):1122–7. doi:.https://doi.org/10.1164/rccm.200712-1841OC
- Taboada D, Pepke-Zaba J, Jenkins DP, Berman M, Treacy CM, Cannon JE, et al. Outcome of pulmonary endarterectomy in symptomatic chronic thromboembolic disease. Eur Respir J. 2014;44(6):1635–45. doi:.https://doi.org/10.1183/09031936.00050114
- Cannon JE, Su L, Kiely DG, Page K, Toshner M, Swietlik E, et al. Dynamic Risk Stratification of Patient Long-Term Outcome After Pulmonary Endarterectomy: Results From the United Kingdom National Cohort. Circulation. 2016;133(18):1761–71. doi:.https://doi.org/10.1161/CIRCULATIONAHA.115.019470
- Hoeper MM, Madani MM, Nakanishi N, Meyer B, Cebotari S, Rubin LJ. Chronic thromboembolic pulmonary hypertension. Lancet Respir Med. 2014;2(7):573–82. doi:.https://doi.org/10.1016/S2213-2600(14)70089-X
- Archibald CJ, Auger WR, Fedullo PF, Channick RN, Kerr KM, Jamieson SW, et al. Long-term outcome after pulmonary thromboendarterectomy. Am J Respir Crit Care Med. 1999;160(2):523–8. doi:.https://doi.org/10.1164/ajrccm.160.2.9808109
- Bonderman D, Skoro-Sajer N, Jakowitsch J, Adlbrecht C, Dunkler D, Taghavi S, et al. Predictors of outcome in chronic thromboembolic pulmonary hypertension. Circulation. 2007;115(16):2153–8. doi:.https://doi.org/10.1161/CIRCULATIONAHA.106.661041
- Jamieson SW, Kapelanski DP, Sakakibara N, Manecke GR, Thistlethwaite PA, Kerr KM, et al. Pulmonary endarterectomy: experience and lessons learned in 1,500 cases. Ann Thorac Surg. 2003;76(5):1457–62, discussion 1462–4. doi:.https://doi.org/10.1016/S0003-4975(03)00828-2
- Thistlethwaite PA, Madani MM, Kemp AD, Hartley M, Auger WR, Jamieson SW. Venovenous extracorporeal life support after pulmonary endarterectomy: indications, techniques, and outcomes. Ann Thorac Surg. 2006;82(6):2139–45. doi:.https://doi.org/10.1016/j.athoracsur.2006.07.020
- Freed DH, Thomson BM, Berman M, Tsui SS, Dunning J, Sheares KK, et al. Survival after pulmonary thromboendarterectomy: effect of residual pulmonary hypertension. J Thorac Cardiovasc Surg. 2011;141(2):383–7. doi:.https://doi.org/10.1016/j.jtcvs.2009.12.056
- Ghofrani HA, D’Armini AM, Grimminger F, Hoeper MM, Jansa P, Kim NH, et al.; CHEST-1 Study Group. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. N Engl J Med. 2013;369(4):319–29. doi:.https://doi.org/10.1056/NEJMoa1209657
- Simonneau G, D’Armini AM, Ghofrani HA, Grimminger F, Hoeper MM, Jansa P, et al. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension: a long-term extension study (CHEST-2). Eur Respir J. 2015;45(5):1293–302. doi:.https://doi.org/10.1183/09031936.00087114
- Simonneau G, D’Armini AM, Ghofrani HA, Grimminger F, Jansa P, Kim NH, et al. Predictors of long-term outcomes in patients treated with riociguat for chronic thromboembolic pulmonary hypertension: data from the CHEST-2 open-label, randomised, long-term extension trial. Lancet Respir Med. 2016;4(5):372–80. doi:.https://doi.org/10.1016/S2213-2600(16)30022-4
- Wiedenroth CB, Liebetrau C, Breithecker A, Guth S, Lautze HJ, Ortmann E, et al. Combined pulmonary endarterectomy and balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension. J Heart Lung Transplant. 2016;35(5):591–6. doi:.https://doi.org/10.1016/j.healun.2015.10.030
- Collaud S, Brenot P, Mercier O, Fadel E. Rescue balloon pulmonary angioplasty for early failure of pulmonary endarterectomy: The earlier the better? Int J Cardiol. 2016;222:39–40. doi:.https://doi.org/10.1016/j.ijcard.2016.07.021
- Shimura N, Kataoka M, Inami T, Yanagisawa R, Ishiguro H, Kawakami T, et al. Additional percutaneous transluminal pulmonary angioplasty for residual or recurrent pulmonary hypertension after pulmonary endarterectomy. Int J Cardiol. 2015;183:138–42. doi:.https://doi.org/10.1016/j.ijcard.2015.01.034
- Federal Statistical Office S. Population of Switzlerland. last accessed 15.03.2018. https://www.bfs.admin.ch/bfs/de/home/statistiken/bevoelkerung.html.
- Feinstein JA, Goldhaber SZ, Lock JE, Ferndandes SM, Landzberg MJ. Balloon pulmonary angioplasty for treatment of chronic thromboembolic pulmonary hypertension. Circulation. 2001;103(1):10–3. doi:.https://doi.org/10.1161/01.CIR.103.1.10
- Sugimura K, Fukumoto Y, Satoh K, Nochioka K, Miura Y, Aoki T, et al. Percutaneous transluminal pulmonary angioplasty markedly improves pulmonary hemodynamics and long-term prognosis in patients with chronic thromboembolic pulmonary hypertension. Circ J. 2012;76(2):485–8. doi:.https://doi.org/10.1253/circj.CJ-11-1217
- Kataoka M, Inami T, Hayashida K, Shimura N, Ishiguro H, Abe T, et al. Percutaneous transluminal pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv. 2012;5(6):756–62. doi:.https://doi.org/10.1161/CIRCINTERVENTIONS.112.971390
- Mizoguchi H, Ogawa A, Munemasa M, Mikouchi H, Ito H, Matsubara H. Refined balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv. 2012;5(6):748–55. doi:.https://doi.org/10.1161/CIRCINTERVENTIONS.112.971077
- Mahmud E, Behnamfar O, Ang L, Patel MP, Poch D, Kim NH. Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension. Interv Cardiol Clin. 2018;7(1):103–17. doi:.https://doi.org/10.1016/j.iccl.2017.09.003
- Andreassen AK, Ragnarsson A, Gude E, Geiran O, Andersen R. Balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension. Heart. 2013;99(19):1415–20. doi:.https://doi.org/10.1136/heartjnl-2012-303549
- Inami T, Kataoka M, Ando M, Fukuda K, Yoshino H, Satoh T. A new era of therapeutic strategies for chronic thromboembolic pulmonary hypertension by two different interventional therapies; pulmonary endarterectomy and percutaneous transluminal pulmonary angioplasty. PLoS One. 2014;9(4):e94587. doi:.https://doi.org/10.1371/journal.pone.0094587
- Inami T, Kataoka M, Yanagisawa R, Ishiguro H, Shimura N, Fukuda K, et al. Long-Term Outcomes After Percutaneous Transluminal Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension. Circulation. 2016;134(24):2030–2. doi:.https://doi.org/10.1161/CIRCULATIONAHA.116.024201
- Taniguchi Y, Miyagawa K, Nakayama K, Kinutani H, Shinke T, Okada K, et al. Balloon pulmonary angioplasty: an additional treatment option to improve the prognosis of patients with chronic thromboembolic pulmonary hypertension. EuroIntervention. 2014;10(4):518–25. doi:.https://doi.org/10.4244/EIJV10I4A89
- Olsson KM, Wiedenroth CB, Kamp JC, Breithecker A, Fuge J, Krombach GA, et al. Balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension: the initial German experience. Eur Respir J. 2017;49(6):1602409. doi:.https://doi.org/10.1183/13993003.02409-2016
- Ghofrani HA, Simonneau G, D’Armini AM, Fedullo P, Howard LS, Jaïs X, et al.; MERIT study investigators. Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study. Lancet Respir Med. 2017;5(10):785–94. doi:.https://doi.org/10.1016/S2213-2600(17)30305-3
- Jaïs X, D’Armini AM, Jansa P, Torbicki A, Delcroix M, Ghofrani HA, et al.; Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension Study Group. Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial. J Am Coll Cardiol. 2008;52(25):2127–34. doi:.https://doi.org/10.1016/j.jacc.2008.08.059
- Bauersachs R, Berkowitz SD, Brenner B, Buller HR, Decousus H, Gallus AS, et al., EINSTEIN Investigators. Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med. 2010;363(26):2499–510. doi:.https://doi.org/10.1056/NEJMoa1007903
- Konstantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galiè N, et al.; Authors/Task Force Members. Corrigendum to: 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2015;36(39):2642. doi:.https://doi.org/10.1093/eurheartj/ehu479